Details for New Drug Application (NDA): 214044
✉ Email this page to a colleague
The generic ingredient in QDOLO is tramadol hydrochloride. There are thirty-six drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the tramadol hydrochloride profile page.
Summary for 214044
Tradename: | QDOLO |
Applicant: | Athena |
Ingredient: | tramadol hydrochloride |
Patents: | 2 |
Pharmacology for NDA: 214044
Mechanism of Action | Full Opioid Agonists |
Medical Subject Heading (MeSH) Categories for 214044
Suppliers and Packaging for NDA: 214044
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
QDOLO | tramadol hydrochloride | SOLUTION;ORAL | 214044 | NDA AUTHORIZED GENERIC | TruPharma, LLC | 52817-615 | 52817-615-16 | 473 mL in 1 BOTTLE (52817-615-16) |
QDOLO | tramadol hydrochloride | SOLUTION;ORAL | 214044 | NDA AUTHORIZED GENERIC | Palmetto Pharmaceuticals, Inc. | 68134-402 | 68134-402-40 | 4 TRAY in 1 CASE (68134-402-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (68134-402-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | 5MG/ML | ||||
Approval Date: | Sep 1, 2020 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 1, 2040 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE AN OPIOID ANALGESIC AND FOR WHICH ALTERNATIVE TREATMENTS ARE INADEQUATE | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 1, 2040 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE AN OPIOID ANALGESIC AND FOR WHICH ALTERNATIVE TREATMENTS ARE INADEQUATE |
Complete Access Available with Subscription